Find a Doctor

Anna-maria Vold-Hoffmann

Oslo University Hospital
Female

Bio


Anna-maria Vold-Hoffmann is in Oslo, Norway. They have been an author on 48 peer reviewed articles in the past 15 years.

Contact

Oslo, NO

Latest Research


Latest Advance
Study
  • Condition: Systemic Sclerosis
  • Journal: PloS one
  • Treatment Used: Fecal Microbiota Transplantation
  • Number of Patients: 10
  • Published —
In this study, researchers evaluated the safety and effectiveness of fecal microbiota transplantation for the treatment of systemic sclerosis.
Latest Advance
Study
  • Condition: Systemic sclerosis
  • Journal: Annals of the rheumatic diseases
  • Treatment Used: Rituximab
  • Number of Patients: 254
  • Published —
The study researched the effects of rituximab in patients with systemic sclerosis.
Latest Advance
Study
  • Condition: Systemic Sclerosis-related Interstitial Lung Disease
  • Journal: The Journal of rheumatology
  • Treatment Used: Cyclophosphamide
  • Number of Patients: 148
  • Published —
In this study, researchers evaluated the outcomes of using cyclophosphamide for the treatment of sclerosis-related interstitial lung disease.

Clinical Trials


This doctor has not participated in any recent clinical trials.

All Publications
View All


Publication
Conference
  • Sponsor: American College of Rheumatology (ACR)
  • Event Name: American College of Rheumatology Annual Scientific Meeting 2020
  • Published —
Resolving Phenotypic and Prognostic Differences in Interstitial Lung Disease Related to Systemic Sclerosis by Computed Tomography-based Radiomics
Publication
Study
  • Journal: Expert review of clinical immunology
  • Published —
The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patients.

Contact

Oslo, NO

Insurance

Contact them to find out if they accept your insurance plan.